Red wine-based drug may help curb obesity, diabetes

08/18/2011 | Daily Mail (London), The

A study in Scientific Reports found that mice taking resveratrol-based SRT1720 drugs did not gain extra weight, had improved stamina and were protected from diabetes despite having a high-fat diet. The drug has also extended the life span of mice in the junk food group by up to 44%. The findings suggest that drugs based on resveratrol, commonly found in red wines, may address obesity, diabetes, heart disease and cancer, experts said.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC